CD4 lymphocytopenia in Systemic Lupus Erythematosus;Linfopenia T CD4 No Lúpus Eritematoso Sistémico

Acta Reumatologica Portuguesa

Volumn 34, Issue 2, 2009, Pages 200-206

  Ferreira, Sofia ^a   Vasconcelos, Júlia ^b   Marinho, António ^c   Farinha, Fátima ^d   Almeida, Isabel ^d   Correia, João ^d   Barbosa, Paulo ^e   Mendonça, Teresa ^d   Vasconcelos, Carlos ^f  

^a Interna Complementar de Medicina Interna   (Portugal)

^b Assistente Hospitalar Graduada de Patologia Clínica   (Brazil)

^c Assistente Hospitalar de Medicina Interna   (Portugal)

^d Assistente Hospitalar Graduado de Medicina Interna   (Portugal)

^e Assistente Hospitalar Graduado   (Portugal)

^f HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

CD4 T Lymphocytes; Lymphocytopenia; Opportunistic infections; SLE Activity; Systemic Lupus Erythematosus

Indexed keywords

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; FEMALE; HUMAN; LYMPHOCYTOPENIA; MALE; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPENIA; MALE; RETROSPECTIVE STUDIES;

EID: 67650188592     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Böhm I. Quantification of absolute peripheral white blood cells and their subsets in patients with lupus erythematosus: comparison with other inflammatory diseases with and without autoimmune background. Biomed Pharmacother 2006;60:92- 95.
2. Miyara M, Amoura Z, Parizot C et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005;175:8392-83400.
3. Crispin Jc, Martínez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lúpus erythematosus. J. Autoimmun 2003;21:273-276.
4. Liu M. F, C. R. Wang, L. L. Fung, C. R. Wu. Decreased CD4+ CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol 2004;59:198-202.
5. Alvarado- Sánchez B, Hernandez-Castro B, Portales-Pérez D et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006; 27:110-118.
6. Valencia X, He L. S, Illei G, Lipsky P. CD4+CD25+ T regulatory cells in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 3404 (Abstr. SY3409).
7. Mudd P.A, Teague B.N, Farris A.D. Regulatory T cells and systemic lupus erythematosus. Scand. J. Immunol 2006;64:211-218.
8. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
9. Gladman D.D, Ibanez D, Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-291.
10. Vitali C, Bencivelli W, Isenberg D. A. et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-547.
11. Gladman D. D, Urowitz M. B, Goldsmith C. H et al. The reliability of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-813.
12. Cook J.R, Gladman D.D, Pericak D, Urowitz M.B. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000;27:1892-1895.
13. Suárez A, López P, Gutiérrez C. Enrichment of CD4+CD25 high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 2006;65:1512-1517.
14. Zandman- Goddar G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005 Nov;38:473-485.
15. Fessler B.J. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002; 16:281-291.
16. Kang I, Park S. H. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003;15:528-534.
17. Paton N. I. Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 1997;26:694-700.
18. Ng W. L, Chu C. M, Wu A. K, Cheng V. C, Yuen K. Y. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM 2006;99:37-47.
19. Le Moing V, Leport C. Infections and lupus. Rev Prat 1998;48:637-642.
20. Baecher-Allan C, Brown J.A, Freeman G.J, Hafler D. A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol 2001;167:1245-1253.
21. Mosca M, Bencivelli W, Vitali C et al. The validity of the ECLAM index for the retrospective evaluation of the disease activity in systemic lupus erythematosus. Lupus 2000;9:445-450
22. Arce-Salinas A, Cardiel M. H, Guzman J, Alcocer-Varela J. Validity of retrospective disease activity assessment in systemic lupus erythematosus. J Rheumatol 1996;23:846-849.
23. Laurence J. T-cell subsets in health, Infectious disease, and idiopathic CD4+ T Lymphocytopenia. Ann Intern Med 1993;119:55-62.
24. Guma M, Krakauer R. Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus. Ann Intern Med 1994;120:168-169.